Tate & Lyle invests in enzyme immobilisation platform Zymtronix
date:Feb 06, 2020
y of biocatalysis.

The company will work with Tate Lyle to advance the use of enzymes in the production of ingredients and to improve its cost-efficiency.

Additionally, retired Tate Lyle chief technology officer Michael Harrison will join the Zymtronix board and support the company by sharing his experience in the food and beverage ingredients market.

Zymtronix founder and CEO-CTO Stphane Corgi said: We are delighted to announce Tate Lyle as our first corporate partner. Their investment wi
3/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/26 08:30